ADNP/ADNP2 expression in oligodendrocytes: implication for myelin-related neurodevelopment

Area of Science:

• Neuroscience
• Cell Biology
• Molecular Biology

Background:

• Oligodendrocytes are crucial for central nervous system myelin formation and maintenance.
• Activity-dependent neuroprotective protein (ADNP) and microtubule end-binding proteins (EB1, EB2, EB3) are vital for brain development and neuronal function.
• The presence and role of ADNP and EBs in oligodendrocytes remained uninvestigated.

Purpose of the Study:

• To investigate the expression patterns of ADNP and EB1-EB3 mRNA in rat oligodendrocytes during maturation and in developing rat brains.
• To compare ADNP and EB expression in oligodendrocytes with other neural cell types like astrocytes and neurons.
• To explore the influence of microtubule-associated protein (MAP) tau on ADNP and EB expression in oligodendroglial cells.

Main Methods:

• Quantitative measurement of ADNP and EB1-EB3 mRNA levels in cultured rat oligodendrocytes at different maturation stages.
• Analysis of mRNA expression in rat brains at postnatal days 1, 35, and 75.
• Comparison of expression levels with rat astrocytes, dorsal root ganglion (DRG) neurons, and oligodendroglial cell lines (OLN-93) with and without tau transfection.

Main Results:

• ADNP and EB2 mRNA expression peaked during oligodendrocyte maturation (5 days in vitro) and were highest in newborn rat brains.
• EB3 mRNA showed a peak during maturation and a second peak at 10 days in vitro, with increased expression in mature rat brains.
• Oligodendrocytes exhibited distinct expression ratios of EB2/EB3 and EB1/EB3 compared to DRG neurons and astrocytes; tau transfection reduced ADNP and EB expression.

Conclusions:

• ADNP and EB family members are significantly expressed in oligodendrocytes, indicating a potential role in myelin formation.
• Expression levels of ADNP and EBs vary with oligodendrocyte maturation, brain development, and cell type.
• The findings suggest that ADNP and EBs are important for oligodendrocyte function in both healthy and diseased states, potentially modulated by tau.